Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Hematologic

The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
Hematologic
III
Kitko, Carrie
NCT03584516
VICCCTT1910

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: